Zhi-Yun Yang (Zhiyun Yang, Lihua Yu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Ejection Fraction

Hepatitis B Virus

Top Venues

Hepatology research : the official journal of the Japan Society of Hepatology

Journal of hepatocellular carcinoma

OncoTargets and therapy

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Wanxin Shi, Huiwen Yan, Xiaoli Liu, Zhi-Yun Yang, Yuqing Xie, Yuan Wu, Yuling Liang, Zhi-Yun Yang
Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8 + T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis. Journal of hepatocellular carcinoma 11 (2024)
Hui Quan, Hao Yu, Xiao-Li Liu, Fei-Xiang Xiong, Yi-Xin Hou, Xian-Bo Wang, Zhi-Yun Yang, Yu-Yong Jiang
Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation. Hepatology research : the official journal of the Japan Society of Hepatology 54 (6) (2024)
Yuling Liang, Yuqing Xie, Xiaoli Liu, Zhi-Yun Yang, Huiwen Yan, Zimeng Shang, Yuan Wu, Xue Cai, Wanxin Shi, Juan Du, Zhi-Yun Yang
Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Astragalus - Atractylodes Herb Pair in Treating Hepatocellular Carcinoma. Drug design, development and therapy 18 (2024)
Hui Quan, Hao Yu, Xiao-Li Liu, Fei-Xiang Xiong, Yi-Xin Hou, Xian-Bo Wang, Zhi-Yun Yang, Yu-Yong Jiang
Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Wanxin Shi, Huiwen Yan, Xiaoli Liu, Zhi-Yun Yang, Yuqing Xie, Yuan Wu, Yuling Liang, Zhi-Yun Yang
Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8 + T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis. Journal of hepatocellular carcinoma 11 (2024)
Hui Quan, Hao Yu, Xiao-Li Liu, Fei-Xiang Xiong, Yi-Xin Hou, Xian-Bo Wang, Zhi-Yun Yang, Yu-Yong Jiang
Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation. Hepatology research : the official journal of the Japan Society of Hepatology 54 (6) (2024)
Yuling Liang, Yuqing Xie, Xiaoli Liu, Zhi-Yun Yang, Huiwen Yan, Zimeng Shang, Yuan Wu, Xue Cai, Wanxin Shi, Juan Du, Zhi-Yun Yang
Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Astragalus - Atractylodes Herb Pair in Treating Hepatocellular Carcinoma. Drug design, development and therapy 18 (2024)
Lihua Yu, Lei Sun, Xiaoli Liu, Xinhui Wang, Huiwen Yan, Qing Pu, Yuqing Xie, Yuyong Jiang, Juan Du, Zhi-Yun Yang
The imbalance of NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of HBV-HCC patients. Hepatology research : the official journal of the Japan Society of Hepatology (2023)
Yuan Wu, Xiaoli Liu, Xinhui Wang, Zhi-Yun Yang, Huiwen Yan, Yuqing Xie, Qing Pu, Xue Cai, Yaxian Kong, Zhi-Yun Yang
A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8 + T Cell Counts and Age. OncoTargets and therapy 16 (2023)
Lihua Yu, Lei Sun, Xiaoli Liu, Xinhui Wang, Huiwen Yan, Qing Pu, Yuqing Xie, Yuyong Jiang, Juan Du, Zhi-Yun Yang
The imbalance between NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of patients with hepatitis B virus-related hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology (2023)
Qing Pu, Zhi-Yun Yang, Xinhui Wang, Huiwen Yan, Yuqing Xie, Juan Du, Zhi-Yun Yang
Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8 + T Cell Counts. OncoTargets and therapy 15 (2022)
Yuqing Xie, Fengna Yan, Xinhui Wang, Zhi-Yun Yang, Huiwen Yan, Qing Pu, Weihong Li, Zhi-Yun Yang
Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma. Cancer medicine (2022)
Zhi-Yun Yang, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Yuyong Jiang, Juan Du, Zhiyun Yang
TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma. Oncoimmunology 10 (1) (2021)
Dongdong Zhou, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Huiwen Yan, Yuyong Jiang, Zhi-Yun Yang
A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC cancer 21 (1) (2021)
Xinhui Wang, Xiaoli Liu, Peng Wang, Zhi-Yun Yang, Fengna Yan, Huiwen Yan, Dongdong Zhou, Zhi-Yun Yang
Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia. Journal of hepatocellular carcinoma 8 (2021)
Xinhui Wang, Xiaoli Liu, Zhibo Dang, Zhi-Yun Yang, Yuyong Jiang, Xian-Bo Wang, Zhiyun Yan
Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis. Gut and liver 14 (2) (2021)